Food and Drug Administration Drug Safety Podcast
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:03:30
- More information
Informações:
Synopsis
Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions.
